Found: 6
Select item for more details and to access through your institution.
Role of L3MBTL3 N183T polymorphism in progression of IgA nephropathy (IgAN).
- Published in:
- Nephrology, 2006, v. 11, p. A61, doi. 10.1111/j.1440-1797.2006.00690.x
- By:
- Publication type:
- Article
The effect of bezafibrate in crescentic glomerulonephritis.
- Published in:
- Nephrology, 2005, v. 10, p. A432, doi. 10.1111/j.1440-1797.2005.00514.x
- By:
- Publication type:
- Article
The clinical course of patients with IgG4-related kidney disease.
- Published in:
- Kidney International, 2013, v. 84, n. 4, p. 826, doi. 10.1038/ki.2013.191
- By:
- Publication type:
- Article
Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.
- Published in:
- Kidney International, 2010, v. 78, n. 10, p. 1016, doi. 10.1038/ki.2010.271
- By:
- Publication type:
- Article
Up-regulation in the kidney and its genetic polymorphism of MUC20, a regulator of Met signaling cascade, in patients with IgA nephropathy.
- Published in:
- Kidney International, 2005, v. 68, n. 5, p. 1970, doi. 10.1111/j.1523-1755.2005.00630_18.x
- By:
- Publication type:
- Article
Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis.
- Published in:
- Kidney International, 2005, v. 67, n. 5, p. 1821, doi. 10.1111/j.1523-1755.2005.00280.x
- By:
- Publication type:
- Article